Fonatsch C., Rieder H., Johansson B:
The role of cytogenetics within the scope of the European LeukemiaNet and Basis and possibilities of a future cooperation between ECA and ELN
ECA Newsletter
16: 26-29 (2005)
Subjects: Cytogenetics
Knuutila S:
A leukemia-enriched cDNA microarray platform identifies new transcripts with relevance to the biology of leukemias
Haematologica
90:866, 2005. Comment
Subjects: Cytogenetics
Lundán T, Volin L. Ruutu T, Knuutila S & Porkka K:
Allogeneic stem cell transplantation reverses the poor prognosis of CML patients with deletions in derivative chromosome 9
Leukemia
19:138-140, 2005
Subjects: Cytogenetics
Meyer C, Schneider B, Reichel M, Angermueller S, Strehl S, Schnittger S, Schoch C, Jansen MW, van Dongen JJ, Pieters R, Haas OA, Dingermann T, Klingebiel T, Marschalek R:
Diagnostic tool for the identification of MLL rearrangements including unknown partner genes
Proc Natl Acad Sci U S A
2005 Jan 11;102(2):449-54
Subjects: Cytogenetics
Nebral K, Konig M, Schmidt HH, Lutz D, Sperr WR, Kalwak K, Brugger S, Dworzak MN, Haas OA, Strehl S.:
Screening for NUP98 rearrangements in hematopoietic malignancies by fluorescence in situ hybridization
Haematologica
2005 Jun;90(6):746-52
Subjects: Cytogenetics
Nebral K, Schmidt HH, Haas OA, Strehl S:
NUP98 is fused to topoisomerase (DNA) IIbeta 180 kDa (TOP2B) in a patient with acute myeloid leukemia with a new t(3;11)(p24;p15)
Clin Cancer Res
2005 Sep 15;11(18):6489-94
Subjects: Cytogenetics
Panzer-Grumayer ER, Cazzaniga G, van der Velden VH, del Giudice L, Peham M, Mann G, Eckert C, Schrauder A, Germano G, Harbott J, Basso G, Biondi A, van Dongen JJ, Gadner H, Haas OA:
Immunogenotype changes prevail in relapses of young children with TEL-AML1-positive acute lymphoblastic leukemia and derive mainly from clonal selection
Clin Cancer Res
2005 Nov 1;11(21):7720-7
Subjects: Cytogenetics
Schoch C., Rieder H., Fonatsch C:
Consensus protocols for cytogenetic diagnostics in leukemia
ELN Information Letter
No.1, 6/2005
Subjects: Cytogenetics
Storlazzi C.T., Fioretos T., Surace C., Lonoce A., Mastrorilli A., Strömbeck B., D’Addabbo P., Iacovelli F., Minervini C., Aventin A., Dastugue N., Fonatsch C., Hagemeijer A., Jotterand M., Mühlematter D., Lafage-Pochitaloff M., Nguyen-Khac F., Schoch C., Slovak M.L., Smith A., Sole F., Van Roy N., Johansson B., Rocchi M:
MYC-containing double minutes in hematologic malignancies: evidence in favour of the episome model and exclusion of MYC as the target gene
Hum Mol Genet
Subjects: Cytogenetics
Tyybäkinoja A, Saarinen-Pihkala U, Elonen E & Knuutila S:
Amplified, lost, and fused genes in 11q23-25 amplicon in acute myeloid leukemia, an array-CGH study
Genes Chromosomes Cancer
Nov 10, 2005
Subjects: AML · Cytogenetics
Zatkova A., Schoch C., Schnittger S., Jotterand M., Ullmann R., Fonatsch C., Wimmer K:
Extensive analysis of the amplicon 11q13.5 frequently co-amplified with the MLL gene in a large collection of AML/MDS patients with MLL amplification
Medgen
17:40 (2005)
Subjects: AML · MDS · Cytogenetics
About us
The objective of the European LeukemiaNet is to integrate the leading leukemia trial groups (CML, AML, ALL, CLL, MDS, CMPD), their interdisciplinary partners (diagnostics, treatment research, registry, guidelines), industry and SMEs across Europe to form a cooperative network for advancements in leukemia-related research and health care and cure.